Saturday, 3 October 2026Updated 19m ago
← Top stories
Expansion● Neutral for Indian equities

Bayer Plans $2.2 Billion US Drug Plant Against Tariff Backdrop

1 source · first seen 00:40 3 Oct · updated 00:40 3 Oct

Tags on this story

Pick a tag to see all its stories
Pharma and healthcare14 todayTrade and tariffs35 today

Linked by the tag Pharma and healthcare

179 stories this week
  1. 2 OctAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combinationDeal · 2 sources
  2. 2 OctHospital stocks: can strong demand offset regulatory risks?Legal · 1 source · Supreme Court scrutiny of medicine mark-ups has raised concerns over hospital margins
  3. 1 OctSEBI clears Carlsberg India, TMC Transformers, Ujin Pharma and Matangi Rubber IPOsIPO · 3 sources · SEBI approved IPOs for Carlsberg India, TMC Transformers, Ujin Pharma and Matangi Rubber
  4. 1 OctWhy the stock market fell for 8th straight week, its longest losing streak in 25 yearsMarket move · 1 source · The market logged its eighth straight weekly decline, the longest losing streak in 25 years
  5. 1 OctHospital stocks extend losses as drug-pricing regulation concerns linger; Apollo, Max among top Nifty losersMarket move · 1 source
All Pharma and healthcare stories →

Read the reports

1 report · earliest 00:40
BloombergBayer Plans $2.2 Billion US Drug Plant Against Tariff Backdrop00:40